Medizone Home

Meet us at CPhI 2021 – Milan 9th to 11th November

We are looking forward to meet you at CPhI Milan from the 9th to 11th November 2021
– please contact
Mr. Robin Mangler – Head of International Pharma Sales –
Mr. Klajdi Drini – Sales Support Manager –
or dial +49 89 1211 2636 and we’ll be happy to arrange an appointment.

For more information visit CPhI exhibitor directory.

Cancellation expopharm 2021

Cancellation expopharm 2021 – largest European trade fair in Düsseldorf will not take place.


Russia registers new Covid-19 drug to keep complications caused by virus ‘under control’

Russian developers have registered a new drug that may help alleviate the harshest complications caused by Covid-19, including lung failure. It’s hoped the treatment can buy time before a vaccine is found.

Levilimab is the second medication to receive state approval through a fast-track mechanism, implemented to give doctors more options to tackle the virus, which has already infected more than 459,000 and killed 5,725 in Russia, according to official statistics.

By reducing the Covid-19 mortality rate, Levilimab will allow Russia to “buy time” before the vaccine against the coronavirus is made, and “the vaccine is surely coming soon,” .

The drug is aimed at curbing the so-called ‘cytokine storm,’ a common complication from Covid-19 when the sick person’s immune system overreacts to the virus and the excessive inflammation leads to fatal outcome.

Levilimab’s highlight is that it can be administered not only to patients already in a serious condition, but used as a prophylactic to “prevent the ‘cytokine storm’ from occurring and allowing the patient to avoid intensive care and lung ventilation,” he pointed out.

The drug, which will go into the market under the brand ILSIRA, is administered hypodermically unlike its foreign counterparts, which get into the system through the intravenous route.

Levilimab has proven itself as effective as its foreign counterparts and increased the speed of recovery for patients, Ekaterina Trifonova, who heads the infectious ward at the Central Clinical Hospital in Moscow, where the drug underwent clinical testing, told RT. During the first two weeks of trials, out of 45 Covid-19 patients who got the drug, ten were discharged, including a 92-year-old-man, while the rest remained in satisfactory condition, she added.

Source: Biocad press release

Medizone supports McDonald’s Kinderhilfe Stiftung

We support McDonald’s Kinderhilfe Stiftung.
At the Ronald McDonald House in Munich-Großhadern families can be close to their badly diseased children and give them all their love and confidence. Medizone enables through the sponsorship of apartment 11, that families with seriously ill children can find a home on time.



Pharmagora Plus – Paris – cancelled June 27-28, 2020 – new dates March 13-14, 2021

Due to the current situation of the coronavirus epidemy, the French Minister of Health, Mr Olivier Véran, has forbidden the organization of any event with more than 5000 delegates in a closed environment. As a result, PharmogaraPlus 2020 will not take place on the 27th and 28th of June 2020 at Paris Porte de Versailles, Hall 3.

PharmagoraPlus is now postponed to the 13th and 14th of March 2021.

We look forward to meeting you soon.


Thanks for visiting us at ARAB HEALTH 2020 – 27 to 30 January

Thank you for visiting us at Arab Health this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

Maktoum Hall – Booth Number M.D33

27th to 30th January 2020.

For more information visit ARAB HEALTH exhibitor directory.


We support “Wings for Life” and “Mc Donalds Kinderhilfe”

On behalf of our team here at Medizone, we would like to thank you for a great year.

We will continue to support “Wings for Life” and “Mc Donalds Kinderhilfe”.

We wish you a great start into a successful New Year 2020.


Thanks for visting us at CPHI in Frankfurt

Thank you for visiting us at CHPI in Frankfurt this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.

More information on the CHPI


„Wings for Life“ honors Medizone for continues support!

Wings for Life – Spinal Cord Research Foundation

Worldwide, millions of people are dependent on a wheelchair after having sustained a spinal cord injury, most often as the result of a traffic accident or a fall. Wings for Life is a not-for-profit spinal cord research foundation with the single mission to find the cure for spinal cord injury. Since 2004, Wings for Life has funded life-changing research projects and clinical trials around the globe. While the cure is still to be found, steady progress has been made. One hundred percent of donations will help work toward Wings for Life’s ultimate goal.

„It can happen to anyone of us. The question is not whether effective treatments and cures will be found, but when they will be found! We are proud to support Wings for Life!“

Gerhard Hoerl / MD Medizone Germany GmbH

Spinal cord injury must become curable!

Thanks for visiting us at Expopharm 2019

Thank you for visiting us at Expopharm in Munich this year!

It was a great pleasure to have the opportunity again to speak in person with many of our business partners.